| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
2 Transactivation Domains of the Rat Glucocorticoid Receptor Constitute a Nuclear Matrix-Targeting Signal
Departments of Biological Sciences (Y.T., D.B.D.), Neuroscience
(D.B.D.), and Pharmacology (D.B.D.) University of Pittsburgh
Pittsburgh, Pennsylvania 15260
Departments of Pathology,
Medicine, Surgery, and Pharmacology and The University of
Pittsburgh Cancer Institute (R.H.G., B.N.V.) University of
Pittsburgh School of Medicine Pittsburgh, Pennsylvania 15213
Departments of Pathology and Biochemistry and Molecular
Biology (M.R.S.) University of Southern California Los
Angeles, California 90033
Genetisches Institut der
Justus-Liebig-Universität (M.E., R.R.) D35392, Giessen,
Germany
Using an ATP-depletion paradigm to augment
glucocorticoid receptor (GR) binding to the nuclear matrix, we have
identified a minimal segment of the receptor that constitutes a nuclear
matrix targeting signal (NMTS). While previous studies implicated a
role for the receptors DNA-binding domain in nuclear matrix
targeting, we show here that this domain of rat GR is necessary, but
not sufficient, for matrix targeting. A minimal NMTS can be generated
by linking the rat GR DNA-binding domain to either its
2
transactivation domain in its natural context, or a heterologous
transactivation domain derived from the Herpes simplex virus VP16
protein. The transactivation and nuclear matrix-targeting activities of
2 are separable, as transactivation mutants were identified that
either inhibited or had no apparent effect on matrix targeting of
2.
A functional interaction between the NMTS of rat GR and the RNA-binding
nuclear matrix protein hnRNP U was revealed in cotransfection
experiments in which hnRNP U overexpression was found to interfere with
the transactivation activity of GR derivatives that possess nuclear
matrix-binding capacity. We have therefore ascribed a novel function to
a steroid hormone transactivation domain that could be an important
component of the mechanism used by steroid hormone receptors to
regulate genes in their native configuration within the nucleus.
This article has been cited by other articles:
![]() |
A. Carrigan, R. F. Walther, H. A. Salem, D. Wu, E. Atlas, Y. A. Lefebvre, and R. J. G. Hache An Active Nuclear Retention Signal in the Glucocorticoid Receptor Functions as a Strong Inducer of Transcriptional Activation J. Biol. Chem., April 13, 2007; 282(15): 10963 - 10971. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Y. Kwok, Y. Wang, C. Y. Wang, and F. C. Leung Cloning of Chicken Glucocorticoid Receptor (GR) and Characterization of its Expression in Pituitary and Extrapituitary Tissues Poult. Sci., February 1, 2007; 86(2): 423 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Seo, M. M. Lozano, and J. P. Dudley Nuclear Matrix Binding Regulates SATB1-mediated Transcriptional Repression J. Biol. Chem., July 1, 2005; 280(26): 24600 - 24609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. Schaaf, L. J. Lewis-Tuffin, and J. A. Cidlowski Ligand-Selective Targeting of the Glucocorticoid Receptor to Nuclear Subdomains Is Associated with Decreased Receptor Mobility Mol. Endocrinol., June 1, 2005; 19(6): 1501 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Herrmann, M. Bossert, A. Schwander, E. Akgun, and F. O. Fackelmayer Arginine Methylation of Scaffold Attachment Factor A by Heterogeneous Nuclear Ribonucleoprotein Particle-associated PRMT1 J. Biol. Chem., November 19, 2004; 279(47): 48774 - 48779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kasai, J. Guerrero-Santoro, R. Friedman, E. S. Leman, R. H. Getzenberg, and D. B. DeFranco The Group 3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in Prostate Cancer Cell Lines Cancer Res., August 15, 2003; 63(16): 4927 - 4935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tazawa, W. Osman, Y. Shoji, E. Treuter, J.-A. Gustafsson, and J. Zilliacus Regulation of Subnuclear Localization Is Associated with a Mechanism for Nuclear Receptor Corepression by RIP140 Mol. Cell. Biol., June 15, 2003; 23(12): 4187 - 4198. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wagner, S. Chiosea, and J. A. Nickerson The spatial targeting and nuclear matrix binding domains of SRm160 PNAS, March 18, 2003; 100(6): 3269 - 3274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. Schaaf and J. A. Cidlowski Molecular Determinants of Glucocorticoid Receptor Mobility in Living Cells: the Importance of Ligand Affinity Mol. Cell. Biol., March 15, 2003; 23(6): 1922 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Barseguian, B. Lutterbach, S. W. Hiebert, J. Nickerson, J. B. Lian, J. L. Stein, A. J. van Wijnen, and G. S. Stein Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins PNAS, November 26, 2002; 99(24): 15434 - 15439. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Ruas, L. Poellinger, and T. Pereira Functional Analysis of Hypoxia-inducible Factor-1alpha -mediated Transactivation. IDENTIFICATION OF AMINO ACID RESIDUES CRITICAL FOR TRANSCRIPTIONAL ACTIVATION AND/OR INTERACTION WITH CREB-BINDING PROTEIN J. Biol. Chem., October 4, 2002; 277(41): 38723 - 38730. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Keeton, T. M. Fletcher, C. T. Baumann, G. L. Hager, and C. L. Smith Glucocorticoid Receptor Domain Requirements for Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter in Different Nucleoprotein Contexts J. Biol. Chem., July 26, 2002; 277(31): 28247 - 28255. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kucera, M. Waltner-Law, D. K. Scott, R. Prasad, and D. K. Granner A Point Mutation of the AF2 Transactivation Domain of the Glucocorticoid Receptor Disrupts Its Interaction with Steroid Receptor Coactivator 1 J. Biol. Chem., July 12, 2002; 277(29): 26098 - 26102. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Chatterjee and R. A. Fisher RGS12TS-S Localizes at Nuclear Matrix-Associated Subnuclear Structures and Represses Transcription: Structural Requirements for Subnuclear Targeting and Transcriptional Repression Mol. Cell. Biol., June 15, 2002; 22(12): 4334 - 4345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Tan, S. H. Hall, K. G. Hamil, G. Grossman, P. Petrusz, and F. S. French Protein Inhibitors of Activated STAT Resemble Scaffold Attachment Factors and Function as Interacting Nuclear Receptor Coregulators J. Biol. Chem., May 3, 2002; 277(19): 16993 - 17001. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshikawa, Y. Makino, K. Okamoto, C. Morimoto, I. Makino, and H. Tanaka Distinct Interaction of Cortivazol with the Ligand Binding Domain Confers Glucocorticoid Receptor Specificity. CORTIVAZOL IS A SPECIFIC LIGAND FOR THE GLUCOCORTICOID RECEPTOR J. Biol. Chem., February 8, 2002; 277(7): 5529 - 5540. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Choi, J. Pratap, A. Javed, S. K. Zaidi, L. Xing, E. Balint, S. Dalamangas, B. Boyce, A. J. van Wijnen, J. B. Lian, et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development PNAS, June 28, 2001; (2001) 151236498. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kotaja, S. Aittomäki, O. Silvennoinen, J. J. Palvimo, and O. A. Jänne ARIP3 (Androgen Receptor-Interacting Protein 3) and Other PIAS (Protein Inhibitor of Activated STAT) Proteins Differ in Their Ability to Modulate Steroid Receptor-Dependent Transcriptional Activation Mol. Endocrinol., December 1, 2000; 14(12): 1986 - 2000. [Abstract] [Full Text] |
||||
![]() |
L. Yang, J. Guerrero, H. Hong, D. B. DeFranco, and M. R. Stallcup Interaction of the tau 2 Transcriptional Activation Domain of Glucocorticoid Receptor with a Novel Steroid Receptor Coactivator, Hic-5, Which Localizes to Both Focal Adhesions and the Nuclear Matrix Mol. Biol. Cell, June 1, 2000; 11(6): 2007 - 2018. [Abstract] [Full Text] |
||||
![]() |
G. S. Stein, M. Montecino, A. J. van Wijnen, J. L. Stein, and J. B. Lian Nuclear Structure-Gene Expression Interrelationships: Implications for Aberrant Gene Expression in Cancer Cancer Res., April 1, 2000; 60(8): 2067 - 2076. [Abstract] [Full Text] |
||||
![]() |
S. Oesterreich, Q. Zhang, T. Hopp, S. A. W. Fuqua, M. Michaelis, H. H. Zhao, J. R. Davie, C. K. Osborne, and A. V. Lee Tamoxifen-Bound Estrogen Receptor (ER) Strongly Interacts with the Nuclear Matrix Protein HET/SAF-B, a Novel Inhibitor of ER-Mediated Transactivation Mol. Endocrinol., March 1, 2000; 14(3): 369 - 381. [Abstract] [Full Text] |
||||
![]() |
H Poukka, U Karvonen, N Yoshikawa, H Tanaka, J. Palvimo, and O. Janne The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor J. Cell Sci., January 9, 2000; 113(17): 2991 - 3001. [Abstract] [PDF] |
||||
![]() |
G. Stein, A. van Wijnen, J. Stein, J. Lian, M Montecino, J Choi, K Zaidi, and A Javed Intranuclear trafficking of transcription factors: implications for biological control J. Cell Sci., January 7, 2000; 113(14): 2527 - 2533. [Abstract] [PDF] |
||||
![]() |
S. McNeil, C. Zeng, K. S. Harrington, S. Hiebert, J. B. Lian, J. L. Stein, A. J. van Wijnen, and G. S. Stein The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha 2 transcription factor PNAS, December 21, 1999; 96(26): 14882 - 14887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Javed, S. Gutierrez, M. Montecino, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian Multiple Cbfa/AML Sites in the Rat Osteocalcin Promoter Are Required for Basal and Vitamin D-Responsive Transcription and Contribute to Chromatin Organization Mol. Cell. Biol., November 1, 1999; 19(11): 7491 - 7500. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Poukka, P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription J. Biol. Chem., July 2, 1999; 274(27): 19441 - 19446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Choi, J. Pratap, A. Javed, S. K. Zaidi, L. Xing, E. Balint, S. Dalamangas, B. Boyce, A. J. van Wijnen, J. B. Lian, et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development PNAS, July 17, 2001; 98(15): 8650 - 8655. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |